NCT02153281

Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer

Neuroimaging MAO-B in Medication Free and Treatment Resistant Major Depressive Disorder Using Novel MAO-B Tracer

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Centre for Addiction and Mental Health · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if monoamine oxidase B (MAO-B) total distribution volume (VT), after phenelzine treatment and if so to what extent.

Detailed description

Subjects will receive a PET and MRI scan before and after treatment with phenelzine.

Conditions

• Major Depressive Disorder

Interventions

Type	Name	Description
OTHER	phenelzine treatment	Subjects will have a PET and MRI scan before and after treatment with phenelzine.

Timeline

• Start date: 2014-06-01
• Primary completion: 2019-05-01
• Completion: 2019-05-01
• First posted: 2014-06-03
• Last updated: 2019-05-24

Locations

1 site across 1 country: Canada